Rocket Pharmaceuticals Inc (RCKT)
SG&A Expenses
$17.43M
Quarterly · Period ending: · USD
RCKT SG&A Expenses
Latest reported$17.43Mperiod ending
Latest reported$17.43Mperiod ending
RCKT Quarterly SG&A Expenses ($82.00K → $17.43M)
Quarterly SG&A Expenses
High-resolution chart · PNG
RCKT sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 17,425,000 | |
| 17,057,000 | |
| 14,684,000 | |
| 18,351,000 | |
| 25,020,000 | |
| 28,446,000 | |
| 25,337,000 | |
| 27,109,000 | |
| 26,581,000 | |
| 21,361,000 | |
| 21,535,000 | |
| 18,585,000 | |
| 17,374,000 | |
| 15,823,000 | |
| 19,045,000 | |
| 15,105,000 | |
| 12,854,000 | |
| 11,770,000 | |
| 12,172,000 | |
| 10,025,000 | |
| 9,518,000 | |
| 10,913,000 | |
| 8,201,000 | |
| 5,730,000 | |
| 6,828,000 | |
| 7,163,000 | |
| 4,981,000 | |
| 4,336,000 | |
| 4,403,000 | |
| 3,808,000 | |
| 2,865,000 | |
| 2,268,000 | |
| 4,100,000 | |
| 8,662,000 | |
| 3,548,000 | |
| 3,895,000 | |
| 2,232,000 | |
| 2,869,000 | |
| 2,746,000 | |
| 2,311,000 | |
| 2,315,000 | |
| 2,522,000 | |
| 2,309,000 | |
| 1,825,000 | |
| 1,728,000 | |
| 1,980,000 | |
| 775,000 | |
| 843,000 | |
| 332,000 | |
| 162,000 | |
| 82,000 |